Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Colorectal Cancer (CRC) · Tumor Infiltrating Lymphocytes · PD-1

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, None Selected, China

    Contact: Study coordinator (Ren Zhao, M.D., Ph.D.) · rjzhaoren@139.com · 86-021-64370045